Across TCGA pan-cancer cohorts, RAET1G RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RAET1G data layer compared with 3 for mutation status.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RAET1G RNA is associated with better overall survival. In most high-consensus cancer types, elevated RAET1G expression acts as an unfavorable survival marker, although some lineages such as KIRC and MESO show a favorable association.
KIRC, MESO, and LIHC are the cancer types where RAET1G RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.